• Ovid Therapeutics Inc. (NASDAQ:OVID) Receives Consensus Rating of "Moderate Buy" from Analysts

    Source: Buzz FX / 23 Nov 2024 04:02:10   America/Chicago


    Ovid Therapeutics Inc. (NASDAQ:OVID) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat November 23, 2024 Share Link copied to clipboard. Ovid Therapeutics Inc. ( NASDAQ:OVID - Get Free Report ) has been assigne
    Read more...
Share on,